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OBJECTIVE—We examined the association between high blood pressure and incident type 2
diabetes in African Americans and whites aged 35–54 years at baseline.
RESEARCH DESIGN AND METHODS—We combined data from the Atherosclerosis
Risk in Communities (ARIC) study, the Coronary Artery Risk Development in Young Adults
(CARDIA) study, and the Framingham Heart Study offspring cohort. Overall, 10,893 participants
(57% women; 23% African American) were categorized by baseline blood pressure (normal, pre-
hypertension, hypertension) and examined for incident diabetes (median follow-up 8.9 years).
RESULTS—Overall,14.6%of AfricanAmericansand7.9%ofwhitesdevelopeddiabetes.Age-
adjusted incidence was increasingly higher across increasing blood pressure groups (P values for
trend:,0.05forAfricanAmericanmen;,0.001forotherrace-sexgroups).Afteradjustmentfor
age, sex, BMI, fasting glucose, HDL cholesterol, and triglycerides, prehypertension or hyperten-
sion (compared with normal blood pressure) was associated with greater risks of diabetes in
whites (hazard ratio [HR] for prehypertension: 1.32 [95% CI 1.09–1.61]; for hypertension: 1.25
[1.03–1.53]), but not African Americans (HR for prehypertension: 0.86 [0.63–1.17]; for hyper-
tension: 0.92 [0.70–1.21]). HRs for developing diabetes among normotensive, prehypertensive,
and hypertensive African Americans versus normotensive whites were: 2.75, 2.28, and 2.36,
respectively (P values ,0.001).
CONCLUSIONS—In African Americans, higher diabetes incidence among hypertensive
individuals may be explained by BMI, fasting glucose, triglyceride, and HDL cholesterol. In
whites, prehypertension and hypertension are associated with greater risk of diabetes, beyond
thatexplainedbyotherriskfactors.AfricanAmericans,regardlessofbloodpressure,havegreater
risks of developing diabetes than whites.
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A
ge, race, and adiposity are well-
established risk factors for type 2
diabetes (1,2). Other cardiometa-
bolic traits such as hypertension, fasting
blood glucose, and lipid levels have also
been identiﬁed as independent variables
in clinical predication models (3). Re-
cently, hypertension has further emerged
as a potential risk factor based on several
longitudinal studies’ ﬁndings that higher
blood pressure is associated with in-
creasedriskofdiabetes(4–9).Thesestud-
ies, however, all had limitations. Some
relied on self-reported diabetes or blood
pressure (4,5,7). Some were single-sex
studies (4,5,7). All but one had few or
n oA f r i c a nA m e r i c a np a r t i c i p a n t s
(4,5,7–9). Most also lacked information
on important baseline characteristics,
such as fasting glucose, lipid proﬁle, or
waist circumference, that could confound
the relationship (4–9). It thus still remains
unclear whether hypertension is associated
with diabetes above and beyond known
risk factors. Large longitudinal studies are
needed to further examine this issue, espe-
cially in order to more precisely estimate
theassociationinAfricanAmericans,apop-
ulation with disproportionate levels of hy-
pertension and diabetes.
We therefore conducted pooled anal-
yses using individual participant-level
data from three large well-characterized
community-based cohort studies in the
U.S. Together, the Atherosclerosis Risk in
Communities (ARIC) study, the Coro-
nary Artery Risk Development in Young
Adults (CARDIA) study, and the Fra-
mingham Heart Study provide a rich
resource to examine whether higher
blood pressure is a risk factor for new-
onset diabetes in middle-aged African
American and white persons in the com-
munity.
RESEARCH DESIGN AND
METHODS—ARIC is a longitudinal
study of 15,792 adults aged 45–64 years
at enrollment in 1987–1989 in four com-
munities: Forsyth County, NC; Jackson,
MS (African Americans only); the north-
westernsuburbsofMinneapolis,MN;and
WashingtonCounty,MD.Participants at-
tended three subsequent examinations
approximately every 3 years (1990–
1992; 1993–1995; and 1996–1999).
CARDIAisalongitudinalstudyinves-
tigating 5,115 African American and
white men and women aged 18–30 years
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ORIGINAL ARTICLEat enrollment in 1985–1986 in four com-
munities: Birmingham, AL; Chicago, IL;
Minneapolis, MN; and Oakland, CA. Par-
ticipant recruitment was approximately
balanced on age, sex, race, and education
statusateachcommunity.Sixsubsequent
examinations were conducted (1987–
1988, 1990–1991, 1992–1993, 1995–
1996, 2000–2001, and 2005–2006).
The offspring cohort of the Framing-
ham Heart Study began in1971–1975,en-
rolling 5,124 offspring and spouses of the
offspring of the Framingham Heart Study’s
original cohort. The offspring cohort par-
ticipants were aged 5–70 years at their ﬁrst
examination. They were next examined 8
years later and then about every 4 years
throughtheseventhexamination,followed
by the eighth examination approximately
6.5 years later (2005–2008).
Detailsofthesethreestudieshavebeen
reported elsewhere (10–12). The studies
wereapprovedbytheirinstitutionalreview
boards of the participating institutions. All
participants provided written informed
consent at each examination.
Participants
Initial eligibility criteria for these analyses
included participants aged 35–54 years
old and nondiabetic (deﬁned as fasting
blood glucose ,126 mg/dL, and no prior
history of and not on medication for di-
abetes) at their index or “baseline” exam-
ination (as detailed below). This yielded
12,119 participants: 8,170 from ARIC,
2,111 from CARDIA, and 1,838 from
the Framingham Heart Study. Partici-
pants were further excluded if they were
not African American or white (n = 30);
failed to return for follow-up or did not
have at least one follow-up visit to deter-
mine diabetes status (n = 709); or at the
index examination were either pregnant
(n = 12), did not fast .8h( n = 330), or
had missing data on systolic (SBP) or di-
astolic blood pressure (DBP) or any of the
following cardiometabolic traits: fasting
blood glucose, insulin, HDL cholesterol
(HDL-C), or triglycerides, waist circum-
ference, or BMI (n = 232). After these ex-
clusions, 10,893 participants remained
eligible. Those excluded were more likely
to be African American (40.5 vs. 23.4%),
notﬁnishedhighschool(21.1vs.12.4%),
have higher SBP (mean 119 vs. 116
mmHg), and prevalence of hypertension
(28.1 vs. 21.5%), consume more alcohol
(mean 4.8 vs. 3.8 drinks/week), and be a
smoker (40.8 vs. 25.2%).
For CARDIA and the Framingham
Heart Study offspring cohort, their ﬁfth
examination cycle (conducted in 1995–
1996 and 1991–1995, respectively) was
considered the index examination, for an
approximate follow-up period of 10 and
14 years, respectively. These were chosen
over prior examinations to ensure a more
contemporary sample while allowing for
sufﬁcient follow-up of approximately 1
decade. Because the most recent ARIC
exam occurred in 1996–1999, its ﬁrst ex-
amination (conducted in 1987–1989)
was considered the index examination,
for 9 years of follow-up.
Assessment of blood pressure,
covariates, and incident diabetes
Blood pressure was measured with par-
ticipants seated after a 5-minute rest
using a random-zero mercury sphygmo-
manometer in ARIC and CARDIA, and a
standard mercury-column sphygmoma-
nometer in the Framingham Heart Study.
The average of two readings was used.
Three mutually exclusive blood pressure
categories were established: hypertension
was deﬁned if SBP $140 mmHg, DBP
$90 mmHg, or reported use of antihy-
pertensive medication; prehypertension
was deﬁned as not having hypertension,
and SBP 120–139 mmHg or DBP 80–89
m m H g ;n o r m a li n c l u d e dS B P,120
mmHg and DBP ,80 mmHg and not us-
ing antihypertensive medication.
Height, weight, and waist circumfer-
ence were measured with participants in
light clothing. BMI was calculated as
weightinkilogramsdividedbythesquare
of height in meters. Waist circumference
wasmeasuredattheleveloftheumbilicus
in ARIC and the Framingham Heart
Study, and at the level of the smallest
waist circumference in CARDIA. Self-
reported information included race, edu-
cation level, parental history of diabetes
(one or both parents with diabetes),
smoking status, alcohol use, and physical
activity. Participants were instructed to
fast overnight before providing blood
specimens for measuring glucose, lipid,
and insulin levels.
Participants were considered to have
incident diabetes if any of the following
was present at a follow-up examination:
fasting blood glucose $126 mg/dL, ca-
sual blood glucose $200 mg/dL, or using
insulin or oral hypoglycemic medication.
Time-to-diabetes was estimated using a
previously described method by Duncan
et al. (13). For cases ascertained based on
bloodglucosevalue,theincidentdatewas
estimated by linear interpolation using
the glucose values at the ascertaining
and previous examinations. For cases as-
certained based on the use of diabetic
medications, the time-to-diabetes was es-
timated by using their fasting glucose at
the earlier visit and a slope estimated us-
ing information from all diabetic subjects
whohadbeenunawareoftheirstatus(be-
cause the fasting glucose at ascertainment
for those who were on diabetic medica-
tion may have been affected by their
knowledge of their diabetes status).
Statistical analysis
Baseline characteristics by study were
examined using simple means and pro-
portions. General linear models were
used to compare characteristics by blood
pressure categories after adjustment for
age and sex (regression models for contin-
uous traits and Poisson regression for cate-
gorical traits). In multivariable analyses,
triglycerides were natural-log transformed
because of their skewed distribution.
Diabetes incidence was calculated us-
ing person-years of observation. Age-spe-
ciﬁc rates were ﬁrst calculated and then
weighted to the standard year 2000 U.S.
population to derive age-adjusted inci-
dence rates by race, sex, and blood pres-
sure category. Conﬁdence intervals and
trend tests across blood pressure category
within race and sex groups were estimated
using 2,000 bootstrap resamples. A stan-
dard normal distribution in the rates was
assumed because the bias between the
sample population estimates and the
mean of the bootstrap estimates was less
than 1%.
Proportional hazards models were
ﬁtted to assess the association of blood
pressure category with incident diabetes.
Tests for effect modiﬁcation by sex were
evaluated in race-speciﬁcm o d e l st h a t
adjusted for age and sex, whereas effect
modiﬁcation by race was tested in age-,
race-, and sex-adjusted models. Effect
modiﬁcation by study was also tested.
Nonproportionality of hazards over time
was tested in race-speciﬁc models using
time-dependent covariates for the blood
pressure categories.
For multivariable analyses, Cox pro-
portional hazards models were construc-
ted to calculate the hazard ratio (HR) and
95% CIs to compare incident diabetes
across blood pressure categories, using
normal blood pressure as the reference
group. The base model adjusted for age
and sex. The second model then added
BMI. The third, considered our primary
model, further adjusted for fasting glu-
cose, HDL-C, and triglyceride. Fasting
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Blood pressure and risk of incident diabetesglucose was included to account for its
potential confounding effect on blood
pressure and incident diabetes because
its levels were positively associated with
increasing blood pressure categories in
both race groups. The fourth model
included a longer list of cardiometabolic
risk factors by also introducing fasting
insulin and waist circumference. To di-
rectly compare the racial differences in the
association of blood pressure and incident
diabetes, we also combined both races in
multivariable analyses with race-speciﬁc
blood pressure categories using normo-
tensive whites as the referent group.
Sensitivity analyses included con-
structing models with additional groups
of covariates or varying the exclusion
criteria. The additional covariates in-
cluded:currentsmoking,alcoholuse,class
of antihypertensive drugs, and physical
activitylevel,aswellaseducationleveland
parental history of diabetes. Finally, be-
cause those with higher blood pressure
also tend to have higher fasting glucose
level, which is a strong predictor of diabe-
tes, we performed separate multivariable
analyses after lowering our exclusion
threshold for baseline fasting glucose to
110 mg/dL from 126 mg/dL (i.e., exclud-
ing individuals with borderline elevated
levels at the index examination).
Antihypertensive medications were
classiﬁed into one of four categories:
b-blockers, thiazides, ACE inhibitors or
angiotensin-receptor blockers, or other
single-agent medications. Combination
or multiple medications were sorted into
nonmutually exclusive categories (for ex-
ample, someone taking a b-blocker and
thiazidewasincludedineachofthosetwo
drug classes). Questionnaires assessing
physical activity were not standardized
across studies. Therefore, each study’s
physical activity summary score (sum of
leisure, sport, and work activity scores in
ARIC and CARDIA, and total physical ac-
tivity in kilocalories over the past year in
Framingham) was standardized (mean =
0, SD = 1) for analytic purposes. To
achieve a normal distribution in the Fra-
mingham physical activity score, natural-
log transformation of the original score
was performed. All analyses were per-
formed using SAS 9.1 (Cary, NC).
RESULTS
Baseline characteristics
More than half (57%) were women.
Nearly one-quarter (23.4%) were African
Americans, all from ARIC and CARDIA.
Meanage(SD)inyearsinCARDIA,ARIC,
and Framingham Heart Study were 37.7
(1.72), 49.9 (3.15), and 47.5 (5.00), re-
spectively (Supplementary Table A). Ta-
ble 1 shows that at baseline, within each
race increasingly higher blood pressure
categories were signiﬁcantly associated
with lower educational level, HDL-C,
and physical activity scores, as well as
older age, higher fasting glucose, triglyc-
erides and insulin levels, and greater
waist circumference, BMI, and alcohol
consumption. Higher blood pressure
was also associated with higher propor-
tionofmen,currentsmoker,andparental
history of diabetes in whites. Overall,
whites had more favorable proﬁles in
blood pressure, adiposity, fasting glucose
andinsulinlevels,prevalenceofsmoking,
and education, whereas African Ameri-
cans had more favorable lipid levels.
Incident diabetes
During median follow-up of 8.9 years,
14.6% (n = 372; 239 women) of African
Americans and 7.9% (n = 657; 271
women) of whites developed diabetes.
Within each race-sex group, age-adjusted
rates were increasingly higher across
baseline blood pressure categories, with
the incidence lowest in the normal blood
pressure group and highest in the hyper-
tension group (Fig. 1) (P values for trend:
,0.05 for African American men;
,0.001 for other race-sex groups). The
rates ranged from 2.8 per 1,000 person-
years in normotensive white women to
28.9 per 1,000 person-years in hyperten-
sive African American women.
Multivariable analyses
The assumption of proportionality of haz-
ards was conﬁrmed. Race-stratiﬁed multi-
variable analyses were performed because
tests for race-by-blood-pressure-category
interactions were signiﬁcant (P values-for-
interaction for prehypertension andhyper-
tension: 0.004 and 0.003, respectively).
Within race-speciﬁc models, effect modiﬁ-
cationbysexwasnotpresent(Pvalues-for-
interaction for prehypertension and
hypertension: 0.68 and 0.92 in African
Americans, and 0.37 and 0.052 in whites,
respectively); therefore, sex-pooled mod-
els were used for all analyses. In models
with interaction terms for study-by-
blood-pressure-category, none of the
terms approached statistical signiﬁcance
(P $ 0.194).
The age- and sex-adjusted HR for
diabetes among African Americans (Table
2) with hypertension was 1.95 (95% CI
1.50–2.54), using normal blood pressure
group as the referent; the risk was not sig-
niﬁcant for prehypertension (P =0 . 2 3 ) .
Afterfurtheradjusting for BMI,thediabe-
tes risk associated with hypertension was
attenuated but remained statistically sig-
niﬁcant (HR 1.48 [95% CI 1.13–1.94]);
butwhenfastingglucose,HDL-C,andtri-
glyceridelevelswereadded,theeffectwas
further attenuated and there was no
longer a signiﬁcant association (0.92
[0.70–1.21]).
Among whites (Table 2), after adjust-
ing for age and sex, compared with nor-
mal blood pressure group, hypertension
had a more than threefold increased risk
of developing diabetes (HR 3.26 [95% CI
2.70–3.94]), and prehypertension had a
twofold increased risk (1.99 [1.64–
2.41]). These associations remained sta-
tistically signiﬁcant, though attenuated,
after also adjusting for BMI, fasting glu-
cose, HDL-C, and triglyceride levels (HR
for prehypertension: 1.32 [95% CI 1.09–
1.61]; for hypertension: 1.25 [1.03–
1.53]).
The race-speciﬁc results remained
similar even when the modeling included
additional baseline covariates (ﬁrst, waist
circumference and fasting insulin; then
also antihypertensive drug class, smok-
ing, alcohol, and physical activity; and
ﬁnally also education level and parental
history of diabetes). Statistically signiﬁ-
cant associations between prehyper-
tension or hypertension and incident
diabetes were again observed in whites
only(SupplementaryTableB).Ofnote,in
the multivariable analyses no antihyper-
tensive drug class was signiﬁcantly asso-
ciated with incident diabetes (results not
shown).
In race-combined primary multivari-
able model (i.e., adjusting for age, sex,
BMI, fasting glucose, HDL-C, and triglyc-
eride) using normotensive whites as ref-
erent, the HR (95% CI) for developing
diabetes in normotensive, prehyperten-
sive, and hypertensive African Americans
were2.75 (2.14–3.53), 2.28(1.76–2.95),
and2.36(1.93–2.90),respectively,andin
prehypertensive and hypertensive whites
were 1.36 (1.12–1.65) and 1.33 (1.10–
1.62), respectively. A similar pattern was
observed after additionally adjusting for
otherdifferencesinbaselinecharacteristics:
education, fasting insulin, waist circumfer-
ence, smoking, alcohol, and parental his-
tory of diabetes (results not shown).
When repeating our primary multi-
variable model after loweringthe baseline
exclusion glucose cut point to 110 mg/dL
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Wei and Associatesfrom 126 mg/dL, the signiﬁcant associa-
tions persisted among whites (HR for
prehypertension: 1.42 [95% CI 1.11–
1.82]; HR for hypertension: 1.52 [1.17–
1.98]). In African Americans, there was
nowatrendtowardhigherriskofdiabetes
in prehypertension group (1.18 [0.80–
1.73])andamarginallystatisticallysignif-
icant association in hypertension group
(1.44 [1.01–2.05]), which was no longer
signiﬁcant after additionally adjusting for
fasting insulin and waist circumference
(P value 0.062). In a race-pooled multi-
variable model with baseline glucose
,110 mg/dL and using normotensive
whites as referent, the race-by-blood-
pressure-category interaction terms were
not signiﬁcant (P values .0.395).
CONCLUSIONS—Middle-aged Afri-
can Americans and whites with higher
blood pressure are more likely to develop
diabetes than those with normal blood
pressure. In African Americans, the
higher incidence of diabetes among hy-
pertensive individuals may be explained
by concomitantly greater adiposity and
other cardiometabolic risk factors. In
whites, the association of both prehyper-
tension and hypertension with incident
diabetes is partially explained by these
and other risk factors. Regardless of base-
line blood pressure status, African Amer-
icans have a greater risk of developing
diabetes than whites.
Only one prior ARIC publication
from a decade ago included substantial
numbers of African Americans when
studying the relationship between blood
pressure and new-onset diabetes; how-
ever, race-speciﬁc results were not pre-
sented (6). We found signiﬁcant race-by-
blood-pressure-category interaction for
incident diabetes in our primary analysis,
thus needing separate analyses by race.
Although after accounting for age- and
sex-differences hypertensive African
Americans were more than twice as likely
to develop diabetes as normotensive Afri-
can Americans, after further adjusting for
baseline BMI, fasting glucose, HDL-C,
and triglyceride levels, the effect size was
greatly attenuated and no longer signiﬁ-
c a n t .F o rw h i t e s ,o u rﬁnding validates
prior reports that high blood pressure
is a risk factor for diabetes (4,5,9). This
ﬁnding is in contrast to a recent paper
from the San Antonio Heart Study, where
no association between prehypertension
and diabetes was observed in 2,767 Mex-
ican Americans and non-Hispanic white
participants after multivariable analysis
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Blood pressure and risk of incident diabetes(14). Although their age-, sex-, and race-
adjusted model of prehypertension was
associated with incident diabetes, it was
no longer signiﬁcant after further adjust-
ing for BMI, impaired glucose tolerance,
insulin resistance and secretion, and fam-
ily history. However, the multivariable-
adjusted odds ratio of incident diabetes
for prehypertension versus normal blood
pressure at 1.42 (95% CI 0.99–2.02) was
comparable to that of our prehypertensive
whites.
African Americans generally have
higher levelsofcardiovascularriskfactors
than whites except for lipid proﬁle
(15,16).Evenafterweaccountedforthese
differences, the racial variation in the as-
sociation between blood pressure and in-
cident diabetes persisted. However,when
lowering the exclusion-criteria threshold
for baseline fasting glucose to 110 mg/dL,
the positive results in whites remained
robust,whereastrendstowardpositiveas-
sociations were newly observed in African
Americans. In a race-pooled model with
this lower exclusion cutpoint and using
normotensive whites as referent, the race-
by-blood pressure-category interaction
terms also became no longer signiﬁcant.
Taken together, this suggests that the
nullassociationfromourprimaryanalyses
of African Americans may have been
largely driven by their higher overall base-
line glucose levels.
Although African Americans are
knowntohave greater risksofdeveloping
diabetes than whites, potentially modiﬁ-
able factors including obesity, education,
physical inactivity, smoking, alcohol, and
dietary intake have accounted for only
about half of the disparity (2). We further
found that this disparity cannot be ex-
plained by African Americans’ higher
prevalenceofprehypertensionandhyper-
tension. Even after accounting for racial
differences in several risk factors, their
risk of diabetes remained higher than
whites across all blood pressure catego-
ries.Notably,educationisalimitedproxy
forsocioeconomicstatus,andothermeas-
uressuchasincomeandhealthcareaccess
are needed. Higher fasting insulin levels
may be one potential biological mecha-
nism to explain the excess incidence of
diabetes, though only in nonobese African
American women (17). Future studies
should investigate additional factors such
as insulin sensitivity, inﬂammation, and
endothelial dysfunction, the pathways of
which, like insulin resistance, are shared
by hypertension and diabetes (13,18–20).
Strengths of the present article in-
clude the large sample size, multiethnic
sample,measuredinsteadofself-reported
blood pressure and blood glucose; and
extensive data on potential confounders.
Limitations should be recognized. First,
as with all observational studies, residual
confounding cannot be ruled out. Sec-
ond, the African American participants
were only from ARIC and CARDIA. In
ARIC, .90% of the African Americans
were recruited from one site (Jackson,
MS).Giventhenonoverlappingage-range
between ARIC and CARDIA participants,
we did not test whether African Ameri-
cansdifferbetweenthesestudies.Though
possiblethattheobservedrace-and-blood
pressure interaction might have been
confounded by racial differences in geo-
graphical distribution, CARDIA included
balanced biracial cohorts from four other
cities, making this concern less likely.
Third, whether causal relationship exists
Figure 1—Age-adjusted rate of incident diabetes and 95% CI by baseline blood pressure category, sex, and race. Rate per 1,000 person-years, age-
adjustedtotheyear2000standardpopulation;95%CIfromnormalapproximationafter2,000bootstrapsamples.Pvaluesfortrendallraceandsex
groups,0.0001,exceptforAfricanAmericanmen,forwhichPvaluefortrendwas0.0219.Normalbloodpressure:SBP,120andDBP,80mmHg
and not using antihypertensive medication; prehypertension: not hypertension and SBP 120–139 or DBP 80–89 mmHg; and hypertension: SBP
$140, DBP $90 mmHg, or using antihypertensive medication. HTN, hypertension.
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Wei and Associatesand whether treating high blood pressure
prevents diabetes are outside the scope of
observational studies. Clinical trials un-
fortunately have also been unable to
address this sufﬁciently. Trials on prehy-
pertension are few and none reported in-
cident diabetes as an outcome (21,22).
For hypertension, several meta-analyses
of antihypertensive drug trials that repor-
ted incident diabetes identiﬁed inhibitors
of the renin-angiotensin system to lower
therisk (23,24).Incontrast,otherantihy-
pertensive drugs such as b-blockers and
diuretics were implicated as putativerisk-
promoting factors (6,25).Moreover, drug
trialshavebeeninherentlylimitedintheir
inability to distinguish any protective ef-
fects of blood pressure-lowering per se
from any direct pharmacological effects
on diabetes development.
In summary, high blood pressure in
middle age is associated with greater
likelihood of developing diabetes. In Af-
rican Americans with hypertension, this
association may be explained by greater
adiposity and other cardiometabolic risk
factors. In whites, both prehypertension
and hypertension are associated with
increased risk of developing diabetes
beyond that explained by adiposity and
other risk factors. Whether lowering
blood pressure slows or prevents the
onset of diabetes deserves further clinical
investigation. Regardless of blood pres-
sure status, African Americans have
greater risks of developing diabetes than
whites. Future studies are also needed to
determine theetiologyfor the excessrisks
in African Americans.
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